Integrating radiosensitivity index and triple-negative breast cancer subtypes reveals SERPINB5 as a radioresistance biomarker in triple-negative breast cancer

Xinxin Rao; Xuanyi Wang; Chao He; YiZhou Jiang; ZhiMing Shao; Yan Feng; Jundong Zhou; Xiaomao Guo; Xingxing Chen

doi:10.1002/ctm2.1787

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (8) : e1787 DOI: 10.1002/ctm2.1787

LETTER TO THE JOURNAL

Integrating radiosensitivity index and triple-negative breast cancer subtypes reveals SERPINB5 as a radioresistance biomarker in triple-negative breast cancer

Xinxin Rao ¹^,²^,³
, Xuanyi Wang ¹^,²^,³
, Chao He ⁴
, YiZhou Jiang ²^,⁵
, ZhiMing Shao ²^,⁵
, Yan Feng ¹^,²^,³
, Jundong Zhou ⁴^,⁶^,^†
, Xiaomao Guo ¹^,²^,³^,^†
, Xingxing Chen ¹^,²^,³^,^†

Author information +

History +

PDF

Cite this article

Download citation ▾

Xinxin Rao, Xuanyi Wang, Chao He, YiZhou Jiang, ZhiMing Shao, Yan Feng, Jundong Zhou, Xiaomao Guo, Xingxing Chen. Integrating radiosensitivity index and triple-negative breast cancer subtypes reveals SERPINB5 as a radioresistance biomarker in triple-negative breast cancer. Clinical and Translational Medicine, 2024, 14(8): e1787 DOI:10.1002/ctm2.1787

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Jiang YZ, Ma D, Suo C, et al. Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies. Cancer Cell. 2019;35:428-440.e425.

[2]	Eschrich SA, Fulp WJ, Pawitan Y, et al. Validation of a radiosensitivity molecular signature in breast cancer. Clin Cancer Res. 2012;18:5134-5143.

[3]	Mohammadi H, Prince A, Figura NB, et al. Using the radiosensitivity index (RSI) to predict pelvic failure in endometrial cancer treated with adjuvant radiation therapy. Int J Radiat Oncol Biol Phys. 2020;106:496-502.

[4]	Strom T, Harrison LB, Giuliano AR, et al. Tumour radiosensitivity is associated with immune activation in solid tumours. Eur J Cancer. 2017;84:304-314.

[5]	Sjöström M, Staaf J, Edén P, et al. Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors. Breast Cancer Res. 2018;20:64.

[6]	Liu YR, Jiang YZ, Xu XE, et al. Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer. Breast Cancer Res. 2016;18:33.

[7]	Zhang P, Li X, He Q, et al. TRIM21–SERPINB5 aids GMPS repression to protect nasopharyngeal carcinoma cells from radiation-induced apoptosis. J Biomed Sci. 2020;27:30.

[8]	Sakabe T, Wakahara M, Shiota G, Umekita Y. Role of cytoplasmic localization of maspin in promoting cell invasion in breast cancer with aggressive phenotype. Sci Rep. 2021;11:11321.

[9]	Li X, Yin S, Meng Y, Sakr W, Sheng S. Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspin. Cancer Res. 2006;66:9323-9329.

[10]	Li X, Kaplun A, Lonardo F, et al. HDAC1 inhibition by maspin abrogates epigenetic silencing of glutathione s-transferase Pi in prostate carcinoma cells. Mol Cancer Res. 2011;9:733-745.

RIGHTS & PERMISSIONS

2024 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.